{
    "title": "Vaccine maker Novavax tops revenue estimates, eyes more cost cuts",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12729911/COVID-vaccine-maker-Novavax-reports-better-expected-revenue.html",
    "date": "2023-11-09",
    "keywords": [
        "year",
        "market",
        "vaccine",
        "company",
        "wingrove",
        "bhanvi",
        "satija",
        "novavax",
        "revenue",
        "cash",
        "end",
        "covid",
        "shot",
        "covid19",
        "jacobs",
        "maker",
        "beat",
        "government",
        "expense",
        "trading",
        "biotech",
        "cost",
        "concern",
        "quarter",
        "leaner",
        "finance",
        "chief",
        "jim",
        "call",
        "reduction",
        "capacity",
        "support",
        "opportunity",
        "something",
        "beginning",
        "ceo",
        "john",
        "interview",
        "population",
        "oct",
        "department",
        "health",
        "spokesperson",
        "sept",
        "june",
        "companys",
        "technology",
        "pfizer",
        "moderna",
        "windfall",
        "filing",
        "approval",
        "pandemic",
        "stock",
        "reporting",
        "bengaluru",
        "york",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}